(386341, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001912', 'increased cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386342, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003219', 'increased spike-wave discharge type II', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386343, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386344, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386345, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0009142', 'decreased prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386346, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386347, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386348, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386349, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0014255', 'increased paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386350, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386351, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003777', 'lip inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386352, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002193', 'minimal clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386353, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003467', 'abnormal single cell response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386354, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386355, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386356, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002064', 'seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386357, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386358, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386359, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386360, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386361, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386362, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010653', 'abnormal Wallerian degeneration', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386363, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386364, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386365, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002915', 'abnormal synaptic depression', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386366, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386367, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003484', 'abnormal channel response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386368, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386369, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008568', 'abnormal interleukin secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386370, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003472', 'increased summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386371, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386372, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003481', 'decreased nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386373, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0006080', 'brain ischemia', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386374, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386375, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386376, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386377, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386378, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386379, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386380, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386381, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386382, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004768', 'abnormal axonal transport', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386383, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386384, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386385, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386386, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003216', 'absence seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386387, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386388, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005025', 'abnormal response to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386389, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386390, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386391, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386392, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386393, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386394, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386395, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386396, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005402', 'abnormal action potential', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386397, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386398, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386399, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0021015', 'increased tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386400, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386401, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386402, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386403, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386404, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386405, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386406, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386407, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008747', 'abnormal T cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386408, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386409, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386410, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386411, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386412, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386413, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386414, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001846', 'increased inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386415, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003463', 'abnormal single cell response', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386416, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031109', 'subarachnoid hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386417, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386418, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386419, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386420, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386421, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011003', 'reduced AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386422, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003997', 'tonic-clonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386423, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008555', 'abnormal interferon secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386424, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386425, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003474', 'abnormal summary potential intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386426, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386427, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386428, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386429, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386430, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386431, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386432, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386433, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386434, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386435, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386436, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386437, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386438, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386439, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386440, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386441, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020000', 'abnormal response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386442, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013806', 'encephalopathy', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386443, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386444, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386445, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386446, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386447, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003483', 'decreased nerve fiber response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386448, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002578', 'impaired ability to fire action potentials', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386449, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386450, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386451, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386452, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386453, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386454, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004752', 'decreased length of allograft survival', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386455, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386456, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386457, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386458, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002916', 'increased synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386459, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386460, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031117', 'subdural hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386461, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386462, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386463, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386464, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001917', 'intraventricular hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386465, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386466, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386467, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386468, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001898', 'abnormal long-term depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386469, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386470, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386471, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386472, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386473, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386474, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386475, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0021001', 'impaired neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386476, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386477, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386478, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386479, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386480, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386481, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386482, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386483, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386484, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386485, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386486, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386487, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386488, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386489, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386490, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386491, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001847', 'brain inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386492, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386493, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386494, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386495, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386496, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002500', 'granulomatous inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386497, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386498, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386499, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386500, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0009358', 'environmentally induced seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386501, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003762', 'abnormal immune organ physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386502, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386503, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020155', 'enhanced humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386504, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001844', 'autoimmune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386505, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386506, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386507, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0009141', 'increased prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386508, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020001', 'decreased response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386509, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386510, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003482', 'increased nerve fiber response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386511, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002635', 'reduced sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386512, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386513, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003488', 'decreased channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386514, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386515, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386516, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003008', 'enhanced long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386517, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386518, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0030129', 'tongue inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386519, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386520, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386521, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386522, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386523, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386524, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386525, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004513', 'avnosmia', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386526, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386527, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012502', 'decreased hindbrain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386528, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386529, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020424', 'increased kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386530, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386531, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386532, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386533, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386534, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386535, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002826', 'tonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386536, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386537, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003470', 'abnormal summary potential', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386538, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020371', 'abnormal glymphatic system physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386539, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386540, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386541, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001916', 'intracerebral hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386542, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005004', 'abnormal lymphocyte anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386543, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003490', 'decreased channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386544, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011994', 'increased nerve conduction velocity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386545, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386546, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386547, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386548, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386549, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011397', 'endoneurial edema', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386550, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002917', 'decreased synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386551, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001475', 'reduced long-term depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386552, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386553, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386554, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386555, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386556, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386557, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386558, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001845', 'abnormal inflammatory response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386559, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0006051', 'brainstem hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386560, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001900', 'impaired synaptic plasticity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386561, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386562, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386563, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386564, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001499', 'abnormal kindling response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386565, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386566, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386567, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386568, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003469', 'decreased single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386569, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386570, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386571, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003464', 'abnormal single cell response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386572, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386573, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386574, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386575, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386576, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386577, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003473', 'decreased summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386578, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386579, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386580, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013438', 'dysmyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386581, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386582, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386583, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386584, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386585, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386586, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386587, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386588, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0030132', 'periodontium inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386589, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386590, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386591, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386592, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386593, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386594, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386595, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386596, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386597, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386598, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386599, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386600, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0009967', 'abnormal neuron proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386601, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001835', 'abnormal antigen presentation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386602, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386603, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386604, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386605, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0006060', 'increased cerebral infarct size', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386606, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003485', 'abnormal channel response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386607, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386608, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386609, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386610, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386611, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386612, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386613, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386614, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386615, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386616, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004994', 'abnormal brain wave pattern', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386617, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002498', 'abnormal acute inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386618, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386619, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386620, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386621, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386622, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386623, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386624, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386625, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386626, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001915', 'intracranial hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386627, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386628, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386629, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012565', 'perivasculitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386630, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386631, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386632, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003487', 'increased channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386633, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002914', 'abnormal endplate potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386634, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386635, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386636, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0006052', 'cerebellum hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386637, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386638, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386639, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386640, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0021027', 'abnormal cerebrospinal fluid amyloid beta 40 isoform level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386641, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386642, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386643, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386644, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003480', 'increased nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386645, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000921', 'demyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386646, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386647, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386648, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386649, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002923', 'increased post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386650, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386651, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386652, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0021010', 'impaired synaptic physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386653, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386654, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001837', 'defective assembly of class I molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386655, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386656, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386657, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386658, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000951', 'sporadic seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386659, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386660, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386661, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004811', 'abnormal neuron physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386662, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008744', 'abnormal B cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386663, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001876', 'decreased inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386664, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386665, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386666, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386667, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386668, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0030153', 'dental pulp inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386669, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386670, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386671, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0014256', 'decreased paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386672, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386673, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386674, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002471', 'abnormal complement pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386675, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386676, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012503', 'increased midbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386677, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386678, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386679, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003635', 'abnormal synaptic transmission', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386680, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0014253', 'decreased paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386681, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031110', 'meningitis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386682, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386683, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003889', 'enhanced sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386684, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003088', 'abnormal prepulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386685, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386686, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005005', 'abnormal self tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386687, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012006', 'abnormal hippocampus physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386688, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003009', 'abnormal cytokine secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386689, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003489', 'increased channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386690, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386691, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386692, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001790', 'abnormal immune system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386693, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386694, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386695, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386696, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002421', 'abnormal cell-mediated immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386697, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386698, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386699, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386700, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386701, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386702, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386703, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386704, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010368', 'abnormal lymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386705, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005645', 'abnormal hypothalamus physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386706, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386707, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003218', 'decreased spike-wave discharge type I', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386708, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386709, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386710, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386711, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386712, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386713, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386714, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386715, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010746', 'abnormal pre-Botzinger complex physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386716, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386717, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386718, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386719, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386720, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0006054', 'spinal hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386721, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386722, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386723, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386724, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013182', 'increased spinal cord apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386725, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386726, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001793', 'abnormal susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386727, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003468', 'increased single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386728, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386729, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386730, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386731, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386732, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386733, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386734, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005043', 'defective assembly of class II molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386735, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386736, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386737, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386738, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003990', 'decreased neurotransmitter release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386739, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386740, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386741, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003217', 'increased spike-wave discharge type I', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386742, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386743, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386744, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0014120', 'focal seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386745, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386746, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386747, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386748, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386749, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386750, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386751, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386752, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386753, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002420', 'abnormal adaptive immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386754, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004494', 'abnormal synaptic glutamate release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386755, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386756, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002920', 'decreased paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386757, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386758, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386759, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386760, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386761, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386762, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002207', 'abnormal long-term potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386763, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386764, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386765, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386766, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386767, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386768, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386769, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386770, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020154', 'impaired humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386771, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386772, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386773, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386774, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386775, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386776, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386777, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386778, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386779, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386780, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003466', 'decreased single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386781, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386782, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386783, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386784, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008814', 'decreased nerve conduction velocity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386785, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010050', 'hypermyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386786, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005001', 'abnormal clonal deletion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386787, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386788, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386789, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386790, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004495', 'decreased synaptic glutamate release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386791, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386792, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003486', 'abnormal channel response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386793, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386794, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386795, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386796, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386797, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0014178', 'increased brain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386798, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008722', 'abnormal chemokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386799, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386800, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386801, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386802, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386803, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002723', 'abnormal immune serum protein physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386804, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003996', 'clonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386805, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001496', 'audiogenic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386806, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386807, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386808, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003465', 'increased single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386809, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386810, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386811, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386812, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002922', 'decreased post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386813, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386814, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386815, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386816, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386817, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386818, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386819, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386820, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386821, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386822, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386823, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010149', 'abnormal synaptic dopamine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386824, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0021009', 'abnormal synaptic physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386825, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005403', 'abnormal nerve conduction', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386826, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386827, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386828, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386829, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386830, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386831, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386832, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386833, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386834, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000947', 'convulsive seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386835, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386836, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386837, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386838, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386839, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005044', 'sepsis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386840, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386841, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386842, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386843, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386844, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386845, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386846, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386847, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386848, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003477', 'abnormal nerve fiber response', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386849, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0000948', 'nonconvulsive seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386850, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386851, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386852, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386853, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386854, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386855, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386856, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386857, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386858, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386859, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003220', 'decreased spike-wave discharge type II', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386860, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386861, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0014254', 'increased paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386862, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004751', 'increased length of allograft survival', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386863, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386864, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386865, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386866, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386867, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386868, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0013596', 'abnormal vomeronasal organ physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386869, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386870, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386871, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003633', 'abnormal nervous system physiology', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386872, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386873, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003475', 'increased summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386874, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386875, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386876, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0003202', 'abnormal neuron apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386877, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386878, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0001500', 'decreased kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(386879, 'HP:0034894', 'Elevated brain polyol compounds by MRS', 'MP:0002499', 'chronic inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386880, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386881, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386882, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386883, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386884, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386885, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386886, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386887, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386888, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386889, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386890, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386891, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386892, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386893, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386894, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386895, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386896, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386897, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386898, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386899, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386900, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386901, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386902, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386903, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386904, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386905, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386906, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386907, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386908, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386909, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386910, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386911, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386912, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386913, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386914, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386915, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386916, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386917, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386918, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386919, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386920, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386921, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386922, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386923, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386924, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386925, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386926, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386927, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386928, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386929, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386930, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386931, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386932, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386933, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386934, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386935, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386936, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386937, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386938, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386939, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386940, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386941, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386942, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386943, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386944, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386945, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386946, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386947, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386948, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386949, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386950, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386951, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386952, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386953, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386954, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386955, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386956, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386957, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386958, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386959, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386960, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386961, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386962, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386963, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386964, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386965, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386966, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386967, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386968, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386969, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386970, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386971, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386972, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386973, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386974, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386975, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386976, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386977, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386978, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386979, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386980, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386981, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386982, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386983, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386984, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386985, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386986, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386987, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386988, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386989, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386990, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386991, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386992, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386993, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386994, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386995, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386996, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386997, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(386998, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(386999, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387000, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387001, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387002, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387003, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387004, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387005, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387006, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387007, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387008, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387009, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387010, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387011, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387012, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387013, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387014, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387015, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387016, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387017, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387018, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387019, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387020, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387021, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387022, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387023, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387024, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387025, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387026, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387027, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387028, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387029, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387030, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387031, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387032, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387033, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387034, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387035, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387036, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387037, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387038, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387039, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387040, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387041, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387042, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387043, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387044, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387045, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387046, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387047, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387048, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387049, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387050, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387051, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387052, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387053, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387054, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387055, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387056, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387057, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387058, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387059, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387060, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387061, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387062, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387063, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387064, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387065, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387066, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387067, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387068, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387069, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387070, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387071, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387072, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387073, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387074, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387075, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387076, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387077, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387078, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387079, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387080, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387081, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387082, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387083, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387084, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387085, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387086, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387087, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387088, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387089, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387090, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387091, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387092, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387093, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387094, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387095, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387096, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387097, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387098, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387099, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387100, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387101, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387102, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387103, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387104, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387105, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387106, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387107, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387108, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387109, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387110, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387111, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387112, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387113, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387114, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387115, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387116, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387117, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387118, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387119, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387120, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387121, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387122, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387123, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387124, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387125, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387126, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387127, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387128, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387129, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387130, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387131, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387132, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387133, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387134, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387135, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387136, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387137, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387138, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387139, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387140, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387141, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387142, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387143, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387144, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387145, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387146, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387147, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387148, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387149, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387150, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387151, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387152, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387153, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387154, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387155, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387156, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387157, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387158, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387159, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387160, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387161, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387162, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387163, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387164, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387165, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387166, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387167, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387168, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387169, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387170, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387171, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387172, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387173, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387174, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387175, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387176, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387177, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387178, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387179, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387180, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387181, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387182, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387183, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387184, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387185, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387186, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387187, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387188, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387189, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387190, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387191, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387192, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387193, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387194, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387195, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387196, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387197, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387198, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387199, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387200, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387201, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387202, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387203, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387204, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387205, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387206, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387207, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387208, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387209, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387210, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387211, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387212, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387213, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387214, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387215, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387216, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387217, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387218, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387219, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387220, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387221, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387222, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387223, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387224, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387225, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387226, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387227, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387228, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387229, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387230, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387231, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387232, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387233, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387234, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387235, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387236, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387237, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387238, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387239, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387240, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387241, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387242, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387243, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387244, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387245, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387246, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387247, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387248, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387249, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387250, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387251, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387252, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387253, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387254, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387255, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387256, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387257, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387258, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387259, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387260, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387261, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387262, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387263, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387264, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387265, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387266, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387267, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387268, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387269, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387270, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387271, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387272, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387273, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387274, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387275, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387276, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387277, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387278, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387279, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387280, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387281, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387282, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387283, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387284, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387285, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387286, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387287, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387288, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387289, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387290, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387291, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387292, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387293, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387294, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387295, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387296, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387297, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387298, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387299, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387300, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387301, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387302, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387303, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387304, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387305, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387306, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387307, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387308, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387309, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387310, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387311, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387312, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387313, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387314, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387315, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387316, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387317, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387318, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387319, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387320, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387321, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387322, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387323, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387324, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387325, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387326, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387327, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387328, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387329, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387330, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387331, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387332, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387333, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387334, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387335, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387336, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387337, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387338, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387339, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387340, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387341, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387342, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387343, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387344, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387345, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387346, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387347, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387348, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387349, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387350, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387351, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387352, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387353, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387354, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387355, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387356, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387357, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387358, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387359, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387360, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387361, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387362, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387363, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387364, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387365, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387366, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387367, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387368, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387369, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387370, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387371, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387372, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387373, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387374, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387375, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387376, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387377, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387378, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387379, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387380, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387381, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387382, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387383, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387384, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387385, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387386, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387387, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387388, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387389, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387390, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387391, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387392, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387393, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387394, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387395, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387396, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387397, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387398, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387399, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387400, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387401, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387402, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387403, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387404, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387405, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387406, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387407, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387408, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387409, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387410, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387411, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387412, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387413, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387414, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387415, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387416, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387417, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387418, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387419, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387420, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387421, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387422, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387423, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387424, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387425, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387426, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387427, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387428, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387429, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387430, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387431, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387432, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387433, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387434, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387435, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387436, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387437, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387438, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387439, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387440, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387441, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387442, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387443, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387444, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387445, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387446, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387447, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387448, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387449, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387450, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387451, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387452, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387453, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387454, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387455, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387456, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387457, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387458, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387459, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387460, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387461, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387462, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387463, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387464, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387465, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387466, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387467, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387468, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387469, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387470, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387471, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387472, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387473, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387474, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387475, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387476, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387477, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387478, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387479, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387480, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387481, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387482, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387483, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387484, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387485, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387486, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387487, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387488, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387489, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387490, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387491, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387492, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387493, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387494, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387495, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387496, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387497, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387498, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387499, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387500, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387501, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387502, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387503, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387504, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387505, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387506, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387507, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387508, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387509, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387510, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387511, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387512, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387513, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387514, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387515, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387516, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387517, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387518, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387519, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387520, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387521, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387522, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387523, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387524, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387525, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387526, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387527, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387528, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387529, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387530, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387531, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387532, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387533, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387534, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387535, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387536, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387537, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387538, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387539, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387540, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387541, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387542, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387543, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387544, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387545, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387546, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387547, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387548, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387549, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387550, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387551, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387552, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387553, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387554, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387555, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387556, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387557, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387558, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387559, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387560, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387561, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387562, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387563, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387564, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387565, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387566, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387567, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387568, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387569, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387570, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387571, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387572, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387573, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387574, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387575, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387576, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387577, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387578, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387579, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387580, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387581, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387582, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387583, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387584, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387585, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387586, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387587, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387588, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387589, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387590, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387591, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387592, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387593, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387594, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387595, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387596, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387597, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387598, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387599, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387600, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387601, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387602, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387603, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387604, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387605, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387606, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387607, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387608, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387609, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387610, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387611, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387612, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387613, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387614, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387615, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387616, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387617, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387618, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387619, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387620, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387621, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387622, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387623, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387624, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387625, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387626, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(387627, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387628, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387629, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(387630, 'HP:0011004', 'Abnormal systemic arterial morphology', 'MP:0005406', 'abnormal heart size', 0.4117647058823529, 5.978701727774094, 1.5690182785726925, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(387631, 'HP:0011004', 'Abnormal systemic arterial morphology', 'MP:0020327', 'abnormal capillary branching pattern', 0.43243243243243246, 6.6481113184978895, 1.6955409014646705, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(387632, 'HP:0011004', 'Abnormal systemic arterial morphology', 'MP:0003141', 'cardiac fibrosis', 0.4117647058823529, 5.978701727774094, 1.5690182785726925, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(387633, 'HP:0011004', 'Abnormal systemic arterial morphology', 'MP:0000255', 'blood vessel congestion', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(387634, 'HP:0011004', 'Abnormal systemic arterial morphology', 'MP:0006133', 'calcified artery', 0.43243243243243246, 6.6481113184978895, 1.6955409014646705, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(387635, 'HP:0011004', 'Abnormal systemic arterial morphology', 'MP:0000265', 'blood vessel atresia', 0.45714285714285713, 6.6481113184978895, 1.7433119636891994, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(387636, 'HP:0011004', 'Abnormal systemic arterial morphology', 'MP:0006134', 'artery occlusion', 0.41025641025641024, 6.6481113184978895, 1.6514933498237148, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(387637, 'HP:0011004', 'Abnormal systemic arterial morphology', 'MP:0013869', 'vascular diverticulum', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(387638, 'HP:0011004', 'Abnormal systemic arterial morphology', 'MP:0011749', 'perivascular fibrosis', 0.41025641025641024, 6.6481113184978895, 1.6514933498237148, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(387639, 'HP:0011004', 'Abnormal systemic arterial morphology', 'MP:0003956', 'abnormal body size', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(387640, 'HP:0011004', 'Abnormal systemic arterial morphology', 'MP:0003719', 'abnormal pericyte morphology', 0.42105263157894735, 6.6481113184978895, 1.6730824144922813, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(387641, 'HP:0011004', 'Abnormal systemic arterial morphology', 'MP:0006083', 'abnormal blood vessel elastic tissue morphology', 0.4117647058823529, 6.6481113184978895, 1.6545263980167935, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(387642, 'HP:0011004', 'Abnormal systemic arterial morphology', 'MP:0006137', 'venoocclusion', 0.41025641025641024, 6.6481113184978895, 1.6514933498237148, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(387643, 'HP:0011004', 'Abnormal systemic arterial morphology', 'MP:0004938', 'dilated vasculature', 0.43243243243243246, 6.6481113184978895, 1.6955409014646705, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(387644, 'HP:0011004', 'Abnormal systemic arterial morphology', 'MP:0012562', 'blood vessel degeneration', 0.45714285714285713, 6.6481113184978895, 1.7433119636891994, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(387645, 'HP:0011004', 'Abnormal systemic arterial morphology', 'MP:0001614', 'abnormal blood vessel morphology', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(387646, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0010016', 'variable depigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387647, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0003705', 'abnormal hypodermis morphology', 0.44, 6.509554027552121, 1.692395867438506, 'UPHENO:0002635', 'abnormal integument'),
(387648, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001191', 'abnormal skin condition', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387649, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001196', 'shiny skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387650, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387651, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0010206', 'pigment incontinence', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387652, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001193', 'psoriasis', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387653, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009385', 'abnormal dermal pigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387654, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0000462', 'abnormal digestive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387655, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0012078', 'abnormal tail ring morphology', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387656, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001246', 'mixed cellular infiltration to dermis', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387657, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0010285', 'decreased skin tumor incidence', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387658, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0000367', 'abnormal coat/ hair morphology', 0.4444444444444444, 6.904974582545727, 1.7518212215413265, 'UPHENO:0003811', 'abnormal skin of body'),
(387659, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0003941', 'abnormal skin development', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387660, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001197', 'oily skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387661, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001231', 'abnormal epidermis stratum basale morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387662, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0004241', 'acantholysis', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387663, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0003196', 'calcified skin', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387664, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0004134', 'abnormal chest morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387665, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009602', 'abnormal keratohyalin granule morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387666, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0002108', 'abnormal muscle morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387667, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0011515', 'purpura', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387668, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0011160', 'dermal-epidermal separation', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387669, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001243', 'abnormal dermal layer morphology', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387670, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0002163', 'abnormal gland morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387671, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0002060', 'abnormal skin morphology', 0.5652173913043478, 7.4735768925632104, 2.055284806280393, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387672, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0005653', 'phototoxicity', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387673, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0008854', 'bleb', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387674, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001209', 'spontaneous skin ulceration', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387675, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001211', 'wrinkled skin', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387676, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0010678', 'abnormal skin adnexa morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387677, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0002897', 'blotchy skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387678, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0002160', 'abnormal reproductive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387679, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0003279', 'aneurysm', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387680, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001239', 'abnormal epidermis stratum granulosum morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387681, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0005500', 'abnormal gustatory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387682, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0005501', 'abnormal skin physiology', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(387683, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0013113', 'greasy tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387684, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001212', 'skin lesions', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387685, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001203', 'increased sensitivity to skin irradiation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387686, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0008856', 'fetal bleb', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387687, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0030923', 'abnormal hair follicle ostium morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387688, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009610', 'abnormal epidermis stratum lucidum morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387689, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0000400', 'abnormal awl hair morphology', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(387690, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009932', 'skin fibrosis', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387691, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0010233', 'hairless tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387692, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009606', 'increased keratohyalin granule size', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387693, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0010071', 'abnormal pruritus', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(387694, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387695, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0003385', 'abnormal body wall morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387696, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387697, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009604', 'increased keratohyalin granule number', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387698, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0013406', 'abnormal epidermal immune compartment', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387699, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009827', 'skin detachment', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387700, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0000685', 'abnormal immune system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387701, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0010700', 'hair follicle comedo', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387702, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009605', 'decreased keratohyalin granule number', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387703, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0005421', 'loose skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387704, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009563', 'dyskeratosis', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387705, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0000428', 'abnormal craniofacial morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387706, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387707, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387708, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0002109', 'abnormal limb morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387709, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0020973', 'abnormal gland development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387710, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001198', 'tight skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387711, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0008419', 'abnormal cutaneous microfibril morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387712, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0002732', 'increased trichoepithelioma incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387713, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001216', 'abnormal epidermal layer morphology', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387714, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387715, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0002925', 'abnormal cardiovascular development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387716, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0000383', 'abnormal hair follicle orientation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387717, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001189', 'absent skin pigmentation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387718, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387719, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0014134', 'abnormal embryo morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387720, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009545', 'abnormal dermis papillary layer morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387721, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009473', 'abnormal skin exfoliation', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(387722, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0005499', 'abnormal olfactory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387723, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009603', 'absent keratohyalin granules', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387724, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0008923', 'thoracoschisis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387725, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0005081', 'abnormal dermis reticular layer morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387726, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0003632', 'abnormal nervous system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387727, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0000397', 'abnormal guard hair morphology', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(387728, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009441', 'delayed skin barrier formation', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387729, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0010300', 'increased skin tumor incidence', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387730, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001195', 'flaky skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387731, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001204', 'decreased sensitivity to skin irradiation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387732, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0000405', 'abnormal auchene hair morphology', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(387733, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0011239', 'abnormal skin coloration', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387734, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009387', 'abnormal epidermal pigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387735, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0003653', 'decreased skin turgor', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387736, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0000574', 'abnormal foot pad morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387737, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0000407', 'abnormal duvet hair morphology', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(387738, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001210', 'skin ridges', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387739, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387740, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0002095', 'abnormal skin pigmentation', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387741, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0005508', 'abnormal skeleton morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387742, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0003853', 'dry skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387743, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009931', 'abnormal skin appearance', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387744, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0005275', 'abnormal skin tensile strength', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(387745, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387746, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0012248', 'absent dermatome', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387747, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0008816', 'petechiae', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387748, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0008418', 'abnormal cutaneous elastic fiber morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387749, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0013118', 'swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387750, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387751, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0005174', 'abnormal tail pigmentation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387752, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001208', 'blistering', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387753, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0031309', 'skin cyst', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387754, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001213', 'abnormal skin cell number', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387755, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0003940', 'abnormal dermatome morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387756, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0002013', 'increased pilomatricoma incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387757, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0002111', 'abnormal tail morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387758, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0000377', 'abnormal hair follicle morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387759, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0031310', 'abnormal cyst', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387760, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0031103', 'skin rash', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387761, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009607', 'decreased keratohyalin granule size', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387762, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0020982', 'abnormal skin adnexa development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387763, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0006281', 'abnormal tail development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387764, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001233', 'abnormal epidermis suprabasal layer morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387765, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0013332', 'peliosis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387766, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0002132', 'abnormal respiratory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387767, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0003652', 'abnormal skin turgor', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387768, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009826', 'abnormal dermis reticular layer collagen network', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387769, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0003717', 'pallor', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387770, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001202', 'skin photosensitivity', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387771, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0002015', 'epithelioid cyst', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387772, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387773, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001510', 'abnormal coat appearance', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(387774, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0000402', 'abnormal zigzag hair morphology', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(387775, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(387776, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0013488', 'increased keratoacanthoma incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387777, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001192', 'scaly skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387778, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001230', 'epidermal desquamation', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387779, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001236', 'abnormal epidermis stratum spinosum morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387780, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0009379', 'abnormal foot pigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387781, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0010232', 'delayed skin pigmentation appearance', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387782, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0014273', 'abnormal skin vasculature morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387783, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0030584', 'skin atrophy', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387784, 'HP:0031512', 'Abnormal cutaneous collagen fibril morphology', 'MP:0001201', 'translucent skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387785, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008596', 'increased circulating interleukin-6 level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387786, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008553', 'increased circulating tumor necrosis factor level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387787, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0002712', 'increased circulating glucagon level', 0.5135135135135135, 11.397693902282326, 2.419270518506053, 'UPHENO:0068533', 'increased level of protein in blood'),
(387788, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0001754', 'increased circulating corticotropin-releasing hormone level', 0.5428571428571428, 11.397693902282326, 2.4874323200749124, 'UPHENO:0068533', 'increased level of protein in blood'),
(387789, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0009060', 'increased circulating interleukin-21 level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387790, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0004702', 'increased circulating insulin-like growth factor I level', 0.5066666666666667, 11.397693902282326, 2.4030879253902424, 'UPHENO:0068533', 'increased level of protein in blood'),
(387791, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008629', 'increased circulating interleukin-9 level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387792, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0005122', 'increased circulating thyroid-stimulating hormone level', 0.4810126582278481, 11.397693902282326, 2.341460023490505, 'UPHENO:0068533', 'increased level of protein in blood'),
(387793, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0002968', 'increased circulating alkaline phosphatase level', 0.5263157894736842, 11.397693902282326, 2.4492419775022474, 'UPHENO:0068533', 'increased level of protein in blood'),
(387794, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0011009', 'increased circulating glutamate dehydrogenase level', 0.5405405405405406, 11.397693902282326, 2.4821191798250366, 'UPHENO:0068533', 'increased level of protein in blood'),
(387795, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008608', 'increased circulating interleukin-13 level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387796, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0004731', 'increased circulating gastrin level', 0.5205479452054794, 11.397693902282326, 2.4357845021499926, 'UPHENO:0068533', 'increased level of protein in blood'),
(387797, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008641', 'increased circulating interleukin-1 beta level', 0.43956043956043955, 11.397693902282326, 2.238297420286804, 'UPHENO:0068533', 'increased level of protein in blood'),
(387798, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0005669', 'increased circulating leptin level', 0.5205479452054794, 11.397693902282326, 2.4357845021499926, 'UPHENO:0068533', 'increased level of protein in blood'),
(387799, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0003352', 'increased circulating renin level', 0.5405405405405406, 11.397693902282326, 2.4821191798250366, 'UPHENO:0068533', 'increased level of protein in blood'),
(387800, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008575', 'increased circulating interferon-beta level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387801, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008593', 'increased circulating interleukin-10 level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387802, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008591', 'increased circulating interleukin-1 level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387803, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008577', 'increased circulating interferon-gamma level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387804, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008623', 'increased circulating interleukin-3 level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387805, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008632', 'increased circulating interleukin-16 level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387806, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0030758', 'increased circulating histamine level', 0.40789473684210525, 9.97294124817027, 2.0169061073744086, 'UPHENO:0082534', 'increased bodily fluid base level'),
(387807, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0011714', 'increased circulating interleukin-8 level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387808, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008626', 'increased circulating interleukin-5 level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387809, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008599', 'increased circulating interleukin-2 level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387810, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008635', 'increased circulating interleukin-18 level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387811, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0011612', 'increased circulating ghrelin level', 0.40789473684210525, 9.97294124817027, 2.0169061073744086, 'UPHENO:0082534', 'increased bodily fluid base level'),
(387812, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0006375', 'increased circulating angiotensinogen level', 0.5194805194805194, 11.397693902282326, 2.4332858338546197, 'UPHENO:0068533', 'increased level of protein in blood'),
(387813, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0002904', 'increased circulating parathyroid hormone level', 0.5205479452054794, 11.397693902282326, 2.4357845021499926, 'UPHENO:0068533', 'increased level of protein in blood'),
(387814, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0005564', 'increased hemoglobin content', 0.40425531914893614, 11.397693902282326, 2.146527052247193, 'UPHENO:0068533', 'increased level of protein in blood'),
(387815, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008644', 'increased circulating interleukin-12a level', 0.46511627906976744, 11.397693902282326, 2.302444999952384, 'UPHENO:0068533', 'increased level of protein in blood'),
(387816, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0030638', 'increased circulating taurine level', 0.4024390243902439, 9.97294124817027, 2.0033723433787505, 'UPHENO:0082534', 'increased bodily fluid base level'),
(387817, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0005124', 'increased circulating prolactin level', 0.475, 11.397693902282326, 2.3267798786271348, 'UPHENO:0068533', 'increased level of protein in blood'),
(387818, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0005309', 'increased circulating ammonia level', 0.40540540540540543, 9.97294124817027, 2.0107422236076804, 'UPHENO:0082534', 'increased bodily fluid base level'),
(387819, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008605', 'increased circulating interleukin-7 level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387820, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008647', 'increased circulating interleukin-12b level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387821, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0002079', 'increased circulating insulin level', 0.5135135135135135, 11.397693902282326, 2.419270518506053, 'UPHENO:0068533', 'increased level of protein in blood'),
(387822, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008611', 'increased circulating interleukin-15 level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387823, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008614', 'increased circulating interleukin-17 level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387824, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008602', 'increased circulating interleukin-4 level', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0068533', 'increased level of protein in blood'),
(387825, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0005610', 'increased circulating antidiuretic hormone level', 0.4189189189189189, 9.97294124817027, 2.043979883982566, 'UPHENO:0082534', 'increased bodily fluid base level'),
(387826, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0005565', 'increased blood urea nitrogen level', 0.4027777777777778, 9.963291078136551, 2.003245426752548, 'UPHENO:0068442', 'increased level of nitrogen molecular entity in blood'),
(387827, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0005343', 'increased circulating aspartate transaminase level', 0.5405405405405406, 11.397693902282326, 2.4821191798250366, 'UPHENO:0068533', 'increased level of protein in blood'),
(387828, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0005568', 'increased circulating total protein level', 0.4857142857142857, 9.97294124817027, 2.200908911069597, 'UPHENO:0082534', 'increased bodily fluid base level'),
(387829, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0008638', 'increased circulating interleukin-1 alpha level', 0.43956043956043955, 11.397693902282326, 2.238297420286804, 'UPHENO:0068533', 'increased level of protein in blood'),
(387830, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0005522', 'increased circulating atrial natriuretic factor', 0.5205479452054794, 11.397693902282326, 2.4357845021499926, 'UPHENO:0068533', 'increased level of protein in blood'),
(387831, 'HP:0032205', 'Increased circulating galectin-3 level', 'MP:0011285', 'increased circulating erythropoietin level', 0.4935064935064935, 11.397693902282326, 2.371673660471797, 'UPHENO:0068533', 'increased level of protein in blood'),
(387832, 'HP:0550003', 'Proximal scleroderma', 'MP:0010973', 'increased periosteum thickness', 0.4523809523809524, 9.62605573046134, 2.0867784403281116, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387833, 'HP:0550003', 'Proximal scleroderma', 'MP:0010692', 'thick hair follicle inner root sheath', 0.44, 9.62605573046134, 2.058024421964664, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387834, 'HP:0550003', 'Proximal scleroderma', 'MP:0009612', 'thick epidermis suprabasal layer', 0.5238095238095238, 9.62605573046134, 2.245488737076384, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387835, 'HP:0550003', 'Proximal scleroderma', 'MP:0011190', 'thick embryonic epiblast', 0.4318181818181818, 9.62605573046134, 2.038800108791518, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387836, 'HP:0550003', 'Proximal scleroderma', 'MP:0009932', 'skin fibrosis', 0.41025641025641024, 7.4735768925632104, 1.7510233658401706, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387837, 'HP:0550003', 'Proximal scleroderma', 'MP:0009600', 'hypergranulosis', 0.5116279069767442, 9.62605573046134, 2.219224807408531, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387838, 'HP:0550003', 'Proximal scleroderma', 'MP:0001244', 'thin dermal layer', 0.4186046511627907, 8.594057268470833, 1.8967109281441068, 'UPHENO:0085691', 'abnormal anatomical entity thickness'),
(387839, 'HP:0550003', 'Proximal scleroderma', 'MP:0004971', 'dermal hyperplasia', 0.4634146341463415, 7.4735768925632104, 1.8610117950813025, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387840, 'HP:0550003', 'Proximal scleroderma', 'MP:0001214', 'skin hyperplasia', 0.4634146341463415, 7.4735768925632104, 1.8610117950813025, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387841, 'HP:0550003', 'Proximal scleroderma', 'MP:0013328', 'visceromegaly', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(387842, 'HP:0550003', 'Proximal scleroderma', 'MP:0004127', 'thick hypodermis', 0.5, 9.62605573046134, 2.1938614052010372, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387843, 'HP:0550003', 'Proximal scleroderma', 'MP:0001264', 'increased body size', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(387844, 'HP:0550003', 'Proximal scleroderma', 'MP:0009599', 'thick epidermis stratum granulosum', 0.5238095238095238, 9.62605573046134, 2.245488737076384, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387845, 'HP:0550003', 'Proximal scleroderma', 'MP:0030584', 'skin atrophy', 0.4146341463414634, 7.4735768925632104, 1.7603409257769456, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387846, 'HP:0550003', 'Proximal scleroderma', 'MP:0001222', 'epidermal hyperplasia', 0.4523809523809524, 7.4735768925632104, 1.8387234246482052, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387847, 'HP:0550003', 'Proximal scleroderma', 'MP:0009601', 'epidermis stratum granulosum hyperplasia', 0.4418604651162791, 7.4735768925632104, 1.817217147682207, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387848, 'HP:0550003', 'Proximal scleroderma', 'MP:0009611', 'epidermis stratum spinosum hyperplasia', 0.4418604651162791, 7.4735768925632104, 1.817217147682207, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387849, 'HP:0550003', 'Proximal scleroderma', 'MP:0001200', 'thick skin', 0.5641025641025641, 9.62605573046134, 2.330253788699296, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387850, 'HP:0550003', 'Proximal scleroderma', 'MP:0004148', 'increased compact bone thickness', 0.41304347826086957, 9.62605573046134, 1.9939858426886405, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387851, 'HP:0550003', 'Proximal scleroderma', 'MP:0031094', 'organomegaly', 0.4444444444444444, 5.9605885577567275, 1.6276211076642195, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(387852, 'HP:0550003', 'Proximal scleroderma', 'MP:0001219', 'thick epidermis', 0.5365853658536586, 9.62605573046134, 2.272707776168618, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387853, 'HP:0550003', 'Proximal scleroderma', 'MP:0003196', 'calcified skin', 0.41025641025641024, 7.4735768925632104, 1.7510233658401706, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387854, 'HP:0550003', 'Proximal scleroderma', 'MP:0010929', 'increased osteoid thickness', 0.4222222222222222, 9.62605573046134, 2.0160195043080176, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387855, 'HP:0550003', 'Proximal scleroderma', 'MP:0001267', 'enlarged chest', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(387856, 'HP:0550003', 'Proximal scleroderma', 'MP:0001218', 'thin epidermis', 0.4090909090909091, 8.594057268470833, 1.875033519897196, 'UPHENO:0085691', 'abnormal anatomical entity thickness'),
(387857, 'HP:0550003', 'Proximal scleroderma', 'MP:0009347', 'increased trabecular bone thickness', 0.4222222222222222, 9.62605573046134, 2.0160195043080176, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387858, 'HP:0550003', 'Proximal scleroderma', 'MP:0009715', 'thick epidermis stratum basale', 0.5238095238095238, 9.62605573046134, 2.245488737076384, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387859, 'HP:0550003', 'Proximal scleroderma', 'MP:0001245', 'thick dermal layer', 0.55, 9.62605573046134, 2.3009412534338503, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387860, 'HP:0550003', 'Proximal scleroderma', 'MP:0010690', 'thick hair follicle outer root sheath', 0.44, 9.62605573046134, 2.058024421964664, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387861, 'HP:0550003', 'Proximal scleroderma', 'MP:0001874', 'acanthosis', 0.4318181818181818, 7.4735768925632104, 1.7964482696212054, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387862, 'HP:0550003', 'Proximal scleroderma', 'MP:0000381', 'enlarged hair follicles', 0.41304347826086957, 7.4735768925632104, 1.7569610680815808, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(387863, 'HP:0550003', 'Proximal scleroderma', 'MP:0009474', 'thick epidermis stratum spinosum', 0.5238095238095238, 9.62605573046134, 2.245488737076384, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387864, 'HP:0550003', 'Proximal scleroderma', 'MP:0000588', 'thick tail', 0.5, 9.62605573046134, 2.1938614052010372, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387865, 'HP:0550003', 'Proximal scleroderma', 'MP:0002953', 'thick ventricular wall', 0.4222222222222222, 9.62605573046134, 2.0160195043080176, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(387866, 'HP:0550003', 'Proximal scleroderma', 'MP:0001199', 'thin skin', 0.42857142857142855, 8.594057268470833, 1.9191579926554285, 'UPHENO:0085691', 'abnormal anatomical entity thickness'),
(387867, 'HP:5200113', 'Offers information', 'MP:0002634', 'abnormal sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387868, 'HP:5200113', 'Offers information', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387869, 'HP:5200113', 'Offers information', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387870, 'HP:5200113', 'Offers information', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387871, 'HP:5200113', 'Offers information', 'MP:0003633', 'abnormal nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387872, 'HP:5200113', 'Offers information', 'MP:0013806', 'encephalopathy', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387873, 'HP:5200113', 'Offers information', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387874, 'HP:5200113', 'Offers information', 'MP:0002635', 'reduced sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387875, 'HP:5200113', 'Offers information', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387876, 'HP:5200113', 'Offers information', 'MP:0012006', 'abnormal hippocampus physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387877, 'HP:5200113', 'Offers information', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387878, 'HP:5200113', 'Offers information', 'MP:0005402', 'abnormal action potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387879, 'HP:5200113', 'Offers information', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387880, 'HP:5200113', 'Offers information', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387881, 'HP:5200113', 'Offers information', 'MP:0004994', 'abnormal brain wave pattern', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387882, 'HP:5200113', 'Offers information', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387883, 'HP:5200113', 'Offers information', 'MP:0003880', 'abnormal central pattern generator function', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387884, 'HP:5200113', 'Offers information', 'MP:0005403', 'abnormal nerve conduction', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387885, 'HP:5200113', 'Offers information', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387886, 'HP:5200113', 'Offers information', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387887, 'HP:5200113', 'Offers information', 'MP:0003477', 'abnormal nerve fiber response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387888, 'HP:5200113', 'Offers information', 'MP:0021015', 'increased tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387889, 'HP:5200113', 'Offers information', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387890, 'HP:5200113', 'Offers information', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387891, 'HP:5200113', 'Offers information', 'MP:0003889', 'enhanced sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387892, 'HP:5200113', 'Offers information', 'MP:0006080', 'brain ischemia', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387893, 'HP:5200113', 'Offers information', 'MP:0003463', 'abnormal single cell response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387894, 'HP:5200113', 'Offers information', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387895, 'HP:5200113', 'Offers information', 'MP:0003470', 'abnormal summary potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(387896, 'HP:0011622', 'Inlet ventricular septal defect', 'MP:0020136', 'abnormal interventricular septum thickness', 0.4375, 13.022184767190119, 2.3868820322013566, 'UPHENO:0019886', 'abnormal interventricular septum morphology'),
(387897, 'HP:0011622', 'Inlet ventricular septal defect', 'MP:0010402', 'ventricular septal defect', 0.5333333333333333, 13.66854781257542, 2.6999800307978004, 'UPHENO:0033604', 'abnormal incomplete closing of the interventricular septum'),
(387898, 'HP:0011622', 'Inlet ventricular septal defect', 'MP:0010419', 'inlet ventricular septal defect', 0.5217391304347826, 13.66854781257542, 2.670471166299938, 'UPHENO:0033604', 'abnormal incomplete closing of the interventricular septum'),
(387899, 'HP:0011622', 'Inlet ventricular septal defect', 'MP:0010403', 'atrial septal defect', 0.40816326530612246, 12.126020578174659, 2.2247238377733547, 'UPHENO:0019888', 'abnormal cardiac septum morphology'),
(387900, 'HP:0011622', 'Inlet ventricular septal defect', 'MP:0010417', 'subarterial ventricular septal defect', 0.5217391304347826, 13.66854781257542, 2.670471166299938, 'UPHENO:0033604', 'abnormal incomplete closing of the interventricular septum'),
(387901, 'HP:0011622', 'Inlet ventricular septal defect', 'MP:0010418', 'perimembraneous ventricular septal defect', 0.48, 13.66854781257542, 2.561425960287785, 'UPHENO:0033604', 'abnormal incomplete closing of the interventricular septum'),
(387902, 'HP:0011622', 'Inlet ventricular septal defect', 'MP:0010420', 'muscular ventricular septal defect', 0.4897959183673469, 13.66854781257542, 2.587430951466796, 'UPHENO:0033604', 'abnormal incomplete closing of the interventricular septum'),
(387903, 'HP:0001680', 'Coarctation of aorta', 'MP:0004938', 'dilated vasculature', 0.40476190476190477, 6.970522647367627, 1.6797029570535724, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(387904, 'HP:0001680', 'Coarctation of aorta', 'MP:0020327', 'abnormal capillary branching pattern', 0.40476190476190477, 6.970522647367627, 1.6797029570535724, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(387905, 'HP:0001680', 'Coarctation of aorta', 'MP:0000265', 'blood vessel atresia', 0.425, 6.970522647367627, 1.7211833502364706, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(387906, 'HP:0001680', 'Coarctation of aorta', 'MP:0010522', 'calcified aorta', 0.40425531914893614, 9.58108497132508, 1.9680458741797906, 'UPHENO:0076809', 'abnormal aorta morphology'),
(387907, 'HP:0001680', 'Coarctation of aorta', 'MP:0012562', 'blood vessel degeneration', 0.425, 6.970522647367627, 1.7211833502364706, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(387908, 'HP:0001680', 'Coarctation of aorta', 'MP:0006133', 'calcified artery', 0.40476190476190477, 6.970522647367627, 1.6797029570535724, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(387909, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0031228', 'decreased angiotensin II level', 0.42857142857142855, 10.243742537047755, 2.0952745340457097, 'UPHENO:0081724', 'decreased level of protein'),
(387910, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0021149', 'abnormal amyloid beta protein level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(387911, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0013215', 'abnormal haptoglobin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(387912, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0021030', 'decreased tumor necrosis factor (ligand) superfamily member 11 level', 0.4444444444444444, 10.243742537047755, 2.1337231453283985, 'UPHENO:0081724', 'decreased level of protein'),
(387913, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0008469', 'abnormal protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(387914, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0020252', 'abnormal collagen level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(387915, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0020297', 'abnormal UDP-N-acetylglucosamine-1-phosphotransferase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(387916, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0020294', 'abnormal guanylate cyclase activating protein-2 level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(387917, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0031337', 'abnormal lipocalin 2 level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(387918, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0008838', 'decreased transforming growth factor beta level', 0.42857142857142855, 10.243742537047755, 2.0952745340457097, 'UPHENO:0081724', 'decreased level of protein'),
(387919, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0002868', 'decreased glutamic acid decarboxylase level', 0.42857142857142855, 10.243742537047755, 2.0952745340457097, 'UPHENO:0081724', 'decreased level of protein'),
(387920, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0008835', 'abnormal intercellular signaling peptide or protein level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(387921, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0021033', 'decreased tumor necrosis factor receptor superfamily member 11b level', 0.4444444444444444, 10.243742537047755, 2.1337231453283985, 'UPHENO:0081724', 'decreased level of protein'),
(387922, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0020291', 'abnormal dystrophin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(387923, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0010999', 'proteinosis', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(387924, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0011288', 'decreased erythropoietin level', 0.42857142857142855, 10.243742537047755, 2.0952745340457097, 'UPHENO:0081724', 'decreased level of protein'),
(387925, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0004893', 'decreased adiponectin level', 0.42857142857142855, 10.243742537047755, 2.0952745340457097, 'UPHENO:0081724', 'decreased level of protein'),
(387926, 'HP:0003637', 'Reduced 4-Hydroxyphenylpyruvate dioxygenase level', 'MP:0012601', 'decreased alpha-fetoprotein level', 0.4444444444444444, 10.243742537047755, 2.1337231453283985, 'UPHENO:0081724', 'decreased level of protein'),
(387927, 'HP:0032556', 'Circumoral cyanosis', 'MP:0001575', 'cyanosis', 0.40425531914893614, 14.491670050491338, 2.4203996986577354, 'UPHENO:0083438', 'abnormally cyan anatomical entity color'),
(387928, 'HP:0032556', 'Circumoral cyanosis', 'MP:0001190', 'reddish skin', 0.42857142857142855, 11.083585311854263, 2.1794742464169388, 'UPHENO:0083450', 'abnormally color anatomical entity color'),
(387929, 'HP:0100587', 'Abnormal preputium morphology', 'MP:0003599', 'large penis', 0.4230769230769231, 12.700256672302759, 2.3180132689881248, 'UPHENO:0087548', 'abnormal penis morphology'),
(387930, 'HP:0100587', 'Abnormal preputium morphology', 'MP:0009202', 'small external male genitalia', 0.425531914893617, 10.825787554386617, 2.1463266546007445, 'UPHENO:0002597', 'abnormal external male genitalia'),
(387931, 'HP:0100587', 'Abnormal preputium morphology', 'MP:0005187', 'abnormal penis morphology', 0.40425531914893614, 12.700256672302759, 2.265865466954108, 'UPHENO:0087548', 'abnormal penis morphology'),
(387932, 'HP:0100587', 'Abnormal preputium morphology', 'MP:0005188', 'small penis', 0.4230769230769231, 12.700256672302759, 2.3180132689881248, 'UPHENO:0087548', 'abnormal penis morphology'),
(387933, 'HP:0100587', 'Abnormal preputium morphology', 'MP:0009200', 'enlarged external male genitalia', 0.425531914893617, 10.825787554386617, 2.1463266546007445, 'UPHENO:0002597', 'abnormal external male genitalia'),
(387934, 'HP:0100587', 'Abnormal preputium morphology', 'MP:0009199', 'abnormal external male genitalia morphology', 0.40476190476190477, 10.825787554386617, 2.093290804226983, 'UPHENO:0002597', 'abnormal external male genitalia'),
(387935, 'HP:0004625', 'Biconvex vertebral bodies', 'MP:0008771', 'elongated vertebral column', 0.42857142857142855, 8.557298718460714, 1.9150492778211121, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(387936, 'HP:0004625', 'Biconvex vertebral bodies', 'MP:0021136', 'abnormal vertebrae shape', 0.4583333333333333, 8.941811350726098, 2.0244333040177263, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(387937, 'HP:0004625', 'Biconvex vertebral bodies', 'MP:0004687', 'split vertebrae', 0.4230769230769231, 8.941811350726098, 1.9450126048433474, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(387938, 'HP:0004625', 'Biconvex vertebral bodies', 'MP:0011175', 'platyspondylia', 0.4107142857142857, 10.93472192593978, 2.1192089338469424, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(387939, 'HP:0004625', 'Biconvex vertebral bodies', 'MP:0021137', 'abnormal wedge-shaped vertebrae', 0.4489795918367347, 8.941811350726098, 2.003669336624705, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(387940, 'HP:0004625', 'Biconvex vertebral bodies', 'MP:0004626', 'vertebral compression', 0.44, 8.941811350726098, 1.983531445256032, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(387941, 'HP:0030995', 'Peritoneal effusion', 'MP:0003300', 'gastrointestinal ulcer', 0.4074074074074074, 5.110459900932426, 1.4429273089447008, 'UPHENO:0002833', 'abnormal digestive system'),
(387942, 'HP:0030995', 'Peritoneal effusion', 'MP:0000462', 'abnormal digestive system morphology', 0.4230769230769231, 5.110459900932426, 1.4704141084723337, 'UPHENO:0002833', 'abnormal digestive system'),
(387943, 'HP:0030995', 'Peritoneal effusion', 'MP:0003119', 'abnormal digestive system development', 0.4074074074074074, 5.110459900932426, 1.4429273089447008, 'UPHENO:0002833', 'abnormal digestive system'),
(387944, 'HP:0030995', 'Peritoneal effusion', 'MP:0010352', 'gastrointestinal tract polyps', 0.4074074074074074, 5.110459900932426, 1.4429273089447008, 'UPHENO:0002833', 'abnormal digestive system'),
(387945, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0002925', 'abnormal cardiovascular development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387946, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387947, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387948, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0013332', 'peliosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387949, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0005508', 'abnormal skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387950, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0004134', 'abnormal chest morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387951, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0010233', 'hairless tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387952, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0002163', 'abnormal gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387953, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0003279', 'aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387954, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0014134', 'abnormal embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387955, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0002132', 'abnormal respiratory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387956, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387957, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0000685', 'abnormal immune system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387958, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387959, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387960, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387961, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0031310', 'abnormal cyst', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387962, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0002160', 'abnormal reproductive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387963, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0020973', 'abnormal gland development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387964, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0020982', 'abnormal skin adnexa development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387965, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0000428', 'abnormal craniofacial morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387966, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.43478260869565216, 5.816527256141925, 1.590259379464479, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(387967, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0003632', 'abnormal nervous system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387968, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0002109', 'abnormal limb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387969, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387970, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0005499', 'abnormal olfactory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387971, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0000462', 'abnormal digestive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387972, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0013113', 'greasy tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387973, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0003385', 'abnormal body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387974, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387975, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0005500', 'abnormal gustatory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387976, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387977, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0008923', 'thoracoschisis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387978, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.47619047619047616, 5.816527256141925, 1.6642640667505584, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(387979, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0002111', 'abnormal tail morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387980, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0012382', 'abnormal blood cell physiology', 0.4166666666666667, 5.816527256141925, 1.5567764847249168, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(387981, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387982, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0006281', 'abnormal tail development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387983, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0002108', 'abnormal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387984, 'HP:0030780', 'Abnormality of the protein C anticoagulant pathway', 'MP:0013118', 'swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(387985, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0020403', 'lysinuria', 0.49382716049382713, 11.226325483970346, 2.354541236956483, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(387986, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0030689', 'cystathioninuria', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(387987, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0030618', 'tryptophanuria', 0.5263157894736842, 11.226325483970346, 2.4307596261219233, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(387988, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0011470', 'increased urine creatinine level', 0.43243243243243246, 11.094077685671904, 2.190305686247806, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(387989, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0020404', 'prolinuria', 0.5063291139240507, 11.226325483970346, 2.38415927213802, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(387990, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0011516', 'aspartylglucosaminuria', 0.5633802816901409, 11.226325483970346, 2.5148937181329196, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(387991, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0020400', 'cystinuria', 0.5263157894736842, 11.226325483970346, 2.4307596261219233, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(387992, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(387993, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0011654', 'histidinuria', 0.5263157894736842, 11.226325483970346, 2.4307596261219233, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(387994, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0020406', 'hyperthreoninuria', 0.5063291139240507, 11.226325483970346, 2.38415927213802, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(387995, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0030614', 'methylmalonic aciduria', 0.4050632911392405, 10.47786425096631, 2.060145183623379, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(387996, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0003311', 'aminoaciduria', 0.5714285714285714, 11.226325483970346, 2.532793543441182, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(387997, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0020405', 'taurinuria', 0.5063291139240507, 11.226325483970346, 2.38415927213802, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(387998, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0020401', 'argininuria', 0.5063291139240507, 11.226325483970346, 2.38415927213802, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(387999, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0030616', 'hyperglycinuria', 0.525, 12.982656403003482, 2.6107268358786273, 'UPHENO:0080641', 'increased level of proteinogenic amino acid in urine'),
(388000, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0011765', 'oroticaciduria', 0.4788732394366197, 10.47786425096631, 2.2399930348635877, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(388001, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0030620', 'valinuria', 0.49382716049382713, 11.226325483970346, 2.354541236956483, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(388002, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0011517', 'hyperoxaluria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(388003, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0013730', 'glutathionuria', 0.4878048780487805, 11.226325483970346, 2.3401402380293517, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(388004, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0030617', 'hyperglutaminuria', 0.5063291139240507, 11.226325483970346, 2.38415927213802, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(388005, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0030682', 'hydroxyprolinuria', 0.49382716049382713, 11.226325483970346, 2.354541236956483, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(388006, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0030613', 'dicarboxylic aciduria', 0.45714285714285713, 10.47786425096631, 2.1885796308203505, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(388007, 'HP:0033095', 'Increased sulfur amino acid level in urine', 'MP:0020402', 'ornithinuria', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(388008, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388009, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388010, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388011, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388012, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388013, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0006082', 'CNS inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388014, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388015, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388016, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388017, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388018, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388019, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388020, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388021, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388022, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388023, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388024, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388025, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388026, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388027, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388028, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388029, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388030, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388031, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388032, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388033, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388034, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388035, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388036, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388037, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388038, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388039, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388040, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388041, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388042, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388043, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388044, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388045, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388046, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0011012', 'bronchiectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388047, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388048, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388049, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388050, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388051, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388052, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388053, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388054, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388055, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388056, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0011763', 'urethritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388057, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0031055', 'bronchitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388058, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388059, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388060, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388061, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388062, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388063, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388064, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388065, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388066, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003777', 'lip inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388067, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388068, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388069, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388070, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388071, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388072, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388073, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388074, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388075, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388076, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388077, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388078, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388079, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388080, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388081, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388082, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388083, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388084, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0012565', 'perivasculitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388085, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0006080', 'brain ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388086, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388087, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388088, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388089, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388090, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388091, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388092, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388093, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388094, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388095, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388096, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388097, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388098, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388099, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388100, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388101, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388102, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388103, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388104, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388105, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388106, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388107, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388108, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388109, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388110, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388111, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388112, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388113, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388114, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388115, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388116, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388117, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388118, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005044', 'sepsis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388119, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388120, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388121, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388122, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388123, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388124, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388125, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388126, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388127, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388128, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388129, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001849', 'ear inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388130, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388131, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388132, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388133, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388134, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388135, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388136, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001844', 'autoimmune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388137, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388138, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388139, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388140, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388141, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388142, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0030990', 'nerve inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388143, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388144, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388145, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388146, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388147, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388148, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388149, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388150, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388151, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388152, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388153, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388154, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388155, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388156, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388157, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388158, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388159, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388160, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388161, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388162, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002933', 'joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388163, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388164, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388165, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388166, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388167, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388168, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388169, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388170, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388171, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388172, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388173, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388174, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388175, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388176, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388177, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388178, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388179, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388180, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388181, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388182, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388183, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388184, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388185, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388186, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388187, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388188, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388189, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388190, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388191, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388192, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388193, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388194, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388195, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388196, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388197, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388198, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388199, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388200, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388201, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388202, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388203, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388204, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388205, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388206, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388207, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388208, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388209, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388210, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388211, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388212, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388213, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388214, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388215, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388216, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388217, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388218, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388219, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388220, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388221, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388222, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388223, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388224, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388225, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388226, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0031053', 'pleuritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388227, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388228, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388229, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388230, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388231, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388232, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388233, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388234, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388235, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388236, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388237, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388238, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388239, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388240, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388241, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388242, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388243, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388244, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388245, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388246, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388247, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388248, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388249, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388250, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0030130', 'gum inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388251, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388252, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388253, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388254, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388255, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388256, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388257, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388258, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388259, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388260, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388261, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388262, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388263, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388264, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388265, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388266, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388267, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0010922', 'alveolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388268, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388269, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388270, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388271, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388272, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388273, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388274, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388275, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388276, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388277, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388278, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388279, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0031095', 'pharyngitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388280, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388281, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388282, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388283, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388284, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001194', 'dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388285, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388286, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388287, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388288, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(388289, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(388290, 'HP:0034145', 'Anti-alanyl-tRNA synthetase antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
